The Negative Pressure Wound Therapy Market is Predict to reach USD 3.7 Billion by 2030, at a CAGR of 6.3%

Negative Pressure Wound Therapy Market Growth, Trends and Report Highlights

According to a new report, published by KBV research, The Global Negative Pressure Wound Therapy Market size is expected to reach $3.7 billion by 2030, rising at a market growth of 6.3% CAGR during the forecast period.

The Hospitals segment is registering a CAGR of 6 % during the forecast period. Hospitals witness a high volume of patients, including those with complex wounds that require advanced care. The prevalence of various types of wounds, such as surgical wounds, trauma-related injuries, and chronic wounds, prompts hospitals to invest in technologies like NPWT for comprehensive wound management. Hospitals extensively use NPWT in postoperative care and the management of surgical wounds. NPWT aids in reducing the risk of postoperative complications, promoting faster healing, and minimizing hospital stays. Surgical departments within hospitals significantly contribute to the demand for NPWT.

The Conventional NPWT segment led the Global Negative Pressure Wound Therapy Market, By Product in 2022; thereby, achieving a market value of $3 billion by 2030. Conventional NPWT is widely used in the management of acute and traumatic wounds, including injuries resulting from accidents, falls, or surgical procedures. The therapy assists in promoting optimal wound healing conditions and minimizing complications. Patients with pressure ulcers, known as bedsores, benefit from conventional NPWT. The therapy helps reduce pressure on the wound, manages exudate, and promotes tissue regeneration, contributing to improved outcomes in pressure ulcer treatment.

The Pressure Ulcers segment is growing at a CAGR of 5.5 % during the forecast period. Pressure ulcers can lead to compromised blood flow and tissue perfusion. NPWT improves tissue perfusion by increasing blood circulation to the affected area, facilitating the delivery of oxygen and nutrients necessary for healing. NPWT is effective in preventing further tissue damage in pressure ulcers. The therapy helps create an environment that supports tissue regeneration, minimizing the risk of the ulcer progressing to more severe stages.

Full Report: https://www.kbvresearch.com/negative-pressure-wound-therapy-market/

The North America region dominated the Global Negative Pressure Wound Therapy Market, By Region in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $1.3 billion by 2030. The Europe region is anticipated to grow at a CAGR of 6.2% during (2023 - 2030). Additionally, The Asia Pacific region would witness a CAGR of 7.1% during (2023 - 2030).

List of Key Companies Profiled

• 3M Company
• Talley Group Ltd. (Direct Healthcare Group)
• Smith & Nephew PLC
• Molnlycke Health Care AB
• DeRoyal Industries, Inc.
• ConvaTec Group PLC
• Cardinal Health, Inc.
• HARTMANN Group (Paul Hartmann AG)
• Cork Medical, LLC

Negative Pressure Wound Therapy Market Report Segmentation

By End-Use

• Hospitals
• Homecare
• Others

By Product

• Conventional NPWT
• Single-use NPWT

By Type

• Pressure Ulcers
• Diabetic Foot Ulcers
• Venous Leg Ulcers
• Burn Wounds
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Related Reports:

North America Negative Pressure Wound Therapy Market Size, 2030

• January-2024
• 95 Pages

LAMEA Negative Pressure Wound Therapy Market Size, Share 2030

• January-2024
• 105 Pages

Europe Negative Pressure Wound Therapy Market Size & 2030

• January-2024
• 103 Pages

Asia Pacific Negative Pressure Wound Therapy Market Size, 2030

• January-2024
• 106 Pages